A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Clinical trial NCT06145373 · RECRUITING
Trial details
- NCT number
- NCT06145373
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2028-05-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.